Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB, Guan KL.

Cell. 2012 Aug 17;150(4):780-91. doi: 10.1016/j.cell.2012.06.037. Epub 2012 Aug 2.

2.

G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.

Zhou X, Wang Z, Huang W, Lei QY.

Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):10-5. doi: 10.1093/abbs/gmu108. Epub 2014 Dec 9. Review.

PMID:
25491506
3.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Zhao B, Lei QY, Guan KL.

Curr Opin Cell Biol. 2008 Dec;20(6):638-46. doi: 10.1016/j.ceb.2008.10.001. Epub 2008 Nov 18. Review.

4.

YAP and TAZ Take Center Stage in Cancer.

Zhang K, Qi HX, Hu ZM, Chang YN, Shi ZM, Han XH, Han YW, Zhang RX, Zhang Z, Chen T, Hong W.

Biochemistry. 2015 Nov 3;54(43):6555-66. doi: 10.1021/acs.biochem.5b01014. Epub 2015 Oct 20. Review.

PMID:
26465056
5.

Disease implications of the Hippo/YAP pathway.

Plouffe SW, Hong AW, Guan KL.

Trends Mol Med. 2015 Apr;21(4):212-22. doi: 10.1016/j.molmed.2015.01.003. Epub 2015 Feb 18. Review.

6.

The Hippo signaling pathway in liver regeneration and tumorigenesis.

Hong L, Cai Y, Jiang M, Zhou D, Chen L.

Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):46-52. doi: 10.1093/abbs/gmu106. Epub 2014 Dec 4. Review.

PMID:
25476204
7.

The regulation and function of YAP transcription co-activator.

Zhu C, Li L, Zhao B.

Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):16-28. doi: 10.1093/abbs/gmu110. Epub 2014 Dec 8. Review.

PMID:
25487920
8.

The Hippo signaling pathway in stem cell biology and cancer.

Mo JS, Park HW, Guan KL.

EMBO Rep. 2014 Jun;15(6):642-56. doi: 10.15252/embr.201438638. Epub 2014 May 12. Review.

9.

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Hong W, Guan KL.

Semin Cell Dev Biol. 2012 Sep;23(7):785-93. doi: 10.1016/j.semcdb.2012.05.004. Epub 2012 May 29. Review.

10.

YAP/TAZ for cancer therapy: opportunities and challenges (review).

Guo L, Teng L.

Int J Oncol. 2015 Apr;46(4):1444-52. doi: 10.3892/ijo.2015.2877. Epub 2015 Feb 5. Review.

PMID:
25652178
11.

Hippo-YAP signaling pathway: A new paradigm for cancer therapy.

Ma Y, Yang Y, Wang F, Wei Q, Qin H.

Int J Cancer. 2015 Nov 15;137(10):2275-86. doi: 10.1002/ijc.29073. Epub 2014 Jul 22. Review.

PMID:
25042563
12.

Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.

Sudol M.

Sci Signal. 2014 Dec 9;7(355):pe29. doi: 10.1126/scisignal.aaa2710. Review.

PMID:
25492964
13.

[Role of the Hippo pathway in cell proliferation and organ size control. Disorders of the pathway in cancer diseases].

Rybarczyk A, Wierzbicki P, Kowalczyk A, Kmieć Z.

Postepy Hig Med Dosw (Online). 2014 May 8;68:503-15. doi: 10.5604/17322693.1101609. Review. Polish.

14.

The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.

Santucci M, Vignudelli T, Ferrari S, Mor M, Scalvini L, Bolognesi ML, Uliassi E, Costi MP.

J Med Chem. 2015 Jun 25;58(12):4857-73. doi: 10.1021/jm501615v. Epub 2015 Mar 11. Review.

PMID:
25719868
15.

Regulation of the Hippo pathway and implications for anticancer drug development.

Park HW, Guan KL.

Trends Pharmacol Sci. 2013 Oct;34(10):581-9. doi: 10.1016/j.tips.2013.08.006. Epub 2013 Sep 16. Review.

16.

The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Kodaka M, Hata Y.

Cell Mol Life Sci. 2015 Jan;72(2):285-306. doi: 10.1007/s00018-014-1742-9. Epub 2014 Sep 30. Review.

PMID:
25266986
17.

Mechanisms of Hippo pathway regulation.

Meng Z, Moroishi T, Guan KL.

Genes Dev. 2016 Jan 1;30(1):1-17. doi: 10.1101/gad.274027.115. Review.

18.

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Yu FX, Zhao B, Guan KL.

Cell. 2015 Nov 5;163(4):811-28. doi: 10.1016/j.cell.2015.10.044. Review.

PMID:
26544935
19.

Targeting YAP and Hippo signaling pathway in liver cancer.

Liu AM, Xu MZ, Chen J, Poon RT, Luk JM.

Expert Opin Ther Targets. 2010 Aug;14(8):855-68. doi: 10.1517/14728222.2010.499361. Review.

PMID:
20545481
20.

Targeting the Hippo Pathway for Anti-cancer Therapies.

Gong R, Yu FX.

Curr Med Chem. 2015;22(35):4104-17. Review.

PMID:
26429069
Items per page

Supplemental Content

Write to the Help Desk